Furukawa, T., Tanji, E., Kuboki, Y., Hatori, T., Yamamoto, M., Shimizu, K., . . . Shiratori, K. (2012). Targeting of MAPK-associated molecules identifies SON as a prime target to attenuate the proliferation and tumorigenicity of pancreatic cancer cells. BioMed Central.
Citação norma ChicagoFurukawa, Toru, Etsuko Tanji, Yuko Kuboki, Takashi Hatori, Masakazu Yamamoto, Kyoko Shimizu, Noriyuki Shibata, and Keiko Shiratori. Targeting of MAPK-associated Molecules Identifies SON As a Prime Target to Attenuate the Proliferation and Tumorigenicity of Pancreatic Cancer Cells. BioMed Central, 2012.
Citação norma MLAFurukawa, Toru, et al. Targeting of MAPK-associated Molecules Identifies SON As a Prime Target to Attenuate the Proliferation and Tumorigenicity of Pancreatic Cancer Cells. BioMed Central, 2012.